Cargando…
Preclinical Assessment of Vernonia amygdalina Leaf Extracts as DNA Damaging Anti-cancer Agent in the Management of Breast Cancer
Breast cancer is the leading cause of death among women between 40 and 55 years of age and is the second overall cause of death among women. Fortunately, the mortality rate from breast cancer has decreased in recent years due to an increased emphasis on early detection and more effective treatments....
Autores principales: | Yedjou, Clement, Izevbigie, Ernest, Tchounwou, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699992/ https://www.ncbi.nlm.nih.gov/pubmed/19151427 |
Ejemplares similares
-
Therapeutic Mechanisms of Vernonia amygdalina Delile in the Treatment of Prostate Cancer
por: Johnson, William, et al.
Publicado: (2017) -
Vernonia amygdalina: Anticancer Activity, Authentication, and Adulteration Detection
por: Gresham, Lecia J., et al.
Publicado: (2008) -
Recent perspectives on the anticancer properties of aqueous extracts of Nigerian Vernonia amygdalina
por: Howard, Carolyn Bingham, et al.
Publicado: (2015) -
ANTIDIABETIC EFFECT OF COMBINED AQUEOUS LEAF EXTRACT OF VERNONIA AMYGDALINA AND METFORMIN IN RATS
por: Michael, U. Adikwu, et al.
Publicado: (2010) -
Effect of aqueous extract of Vernonia amygdalina on atherosclerosis in rabbits
por: Abdulmalik, Omotola, et al.
Publicado: (2016)